Hanmi Unveil P3 Clinical Trial Results for Asthma-rhinitis Combination Drug

Aug 22, 2018 | Allergies, Korea

Lee Han-Soo of Korean Biomedical Review writes that Hanmi Pharmaceutical said that it has presented the phase 3 clinical trial results for Monterizine, a combination treatment for asthma and allergic rhinitis, on Clinical Therapeutics, a Science Citation Index (SCI) level medical journal.


Pin It on Pinterest